GLP-1s, Protein, and Muscle: What Happens When You’re Eating Less?

GLP-1s have changed the conversation around weight loss.

A lot of that conversation understandably focuses on the number on the scale. But there’s another part of the story that researchers are paying increasing attention to: What happens nutritionally when someone simply isn’t eating very much?

Reduced appetite is part of how GLP-1-based therapies can lead to weight loss. But eating less can also mean consuming less protein, fewer vitamins and minerals, and fewer calories overall.

And when weight starts coming off quickly, researchers aren’t just interested in how much weight is lost. They’re also interested in what kind of weight is being lost.

First, What Do We Mean by “GLP-1s”?

“GLP-1” has become a catch-all term in everyday conversation, but the science is a little more complicated.

Some medications act primarily on the GLP-1 receptor. Others target more than one receptor. Tirzepatide, for example, acts on both GIP and GLP-1 receptors. Investigational compounds are being studied that target even more pathways.

For simplicity, we’re using “GLP-1s” broadly in this article to talk about this growing category of incretin-based therapies. Interestingly, a 2025 joint nutrition advisory published in The American Journal of Clinical Nutrition uses the term in much the same way, acknowledging that it has become common shorthand for GLP-1 receptor agonists and related combination medications.

Regardless of the specific compound, one thing many of these therapies have in common is a reduction in appetite and overall food intake.

And that’s where nutrition becomes particularly interesting.

What Happens When You’re Just Not That Hungry?

Eating less sounds simple until you actually think about what “less” means.

If someone goes from eating three substantial meals a day to eating much smaller portions, skipping meals, or simply forgetting to eat because they aren’t hungry, they’re not only consuming fewer calories.

They may also be consuming less:

• Protein
• Fiber
• Calcium
• Iron
• Vitamin B12
• Vitamin D
• Other vitamins and minerals

The joint nutrition advisory on GLP-1 therapy notes that reduced appetite, changes in food preferences, and gastrointestinal side effects can make adequate nutrition more difficult. It identifies several nutrients that may be of concern when food and calorie intake are significantly reduced.

That’s an important distinction. Eating fewer calories and eating nutritionally well aren’t automatically the same thing.

Why Is Everyone Talking About Protein?

Protein has become one of the biggest nutrition conversations surrounding GLP-1s, and there’s a reason for it.

When people lose a significant amount of weight, they don’t lose body fat exclusively. Some lean mass is generally lost as well.

“Lean mass” is another term that can sound more alarming than it needs to. It doesn’t mean every pound of lean mass lost is a pound of muscle. Lean mass measurements include muscle and other non-fat tissues.

Still, researchers are paying close attention to muscle.

Research from the SURMOUNT-1 trial examining body composition during weight loss with tirzepatide found reductions in both fat mass and lean mass, with substantially more fat mass lost than lean mass.

And this isn’t necessarily something unique to GLP-1s. A 2026 systematic review and meta-analysis of randomized trials found that lean mass accounted for a meaningful portion of total weight lost with incretin-based therapies. However, the proportion was broadly comparable to that seen with lifestyle-based weight loss.

That’s one reason the conversation shouldn’t simply be:

“Do GLP-1s cause muscle loss?”

A better question may be:

“During significant weight loss, what can help preserve muscle and physical function?”

Protein Is Part of the Picture, but Not the Whole Picture

Getting adequate protein gives the body amino acids needed to maintain and repair tissue.

The challenge is that protein can become surprisingly difficult to prioritize when appetite is low.

A large steak or chicken breast might not sound particularly appealing when you’re barely hungry. Even foods someone normally enjoys may suddenly seem like too much.

That’s why current nutrition discussions around GLP-1 therapy increasingly focus on nutrient-dense foods that provide useful nutrition without requiring someone to eat an enormous amount of food.

The American Journal of Clinical Nutrition advisory discusses foods such as fish, eggs, Greek yogurt, cottage cheese, nuts, seeds, beans, peas, and lentils. It also notes that protein drinks and other fortified products may sometimes help when adequate protein is difficult to obtain through regular food alone.

There isn’t one universal protein target that’s right for everyone. Needs can vary based on factors such as body composition, age, activity level, and health.

That’s something to discuss with a physician or registered dietitian rather than pulling a protein number from social media.

What About Strength Training?

Here’s another piece of the puzzle that’s easy to overlook.

Protein alone isn’t the entire answer.

Muscle responds to being used.

Resistance training gives muscles a reason to keep working and adapting during weight loss. And research increasingly points toward combining adequate nutrition with resistance exercise rather than thinking about protein in isolation.

The same 2026 analysis comparing incretin therapies with lifestyle interventions found that lifestyle programs incorporating resistance training had a more favorable lean-mass preservation profile than lifestyle intervention alone.

That doesn’t mean everyone needs to become a bodybuilder.

Resistance exercise can take many forms, including weights, resistance bands, machines, and body-weight exercises. What’s appropriate depends on the individual.

The larger point is that weight loss and muscle preservation don’t necessarily happen automatically at the same time.

The Scale Doesn’t Tell the Whole Story

This may be one of the most interesting changes happening in weight-loss research.

For decades, success was often discussed primarily in pounds lost or percentage of body weight lost.

Researchers are now paying much closer attention to body composition.

Two people could each lose 30 pounds but experience different changes in fat mass, lean mass, strength, and overall nutrition.

There’s another important wrinkle here. Lean mass and skeletal muscle aren’t interchangeable terms. Changes detected on a body-composition scan don’t automatically tell researchers exactly what happened to someone’s muscle strength or physical function.

A 2026 review of lean mass and musculoskeletal preservation during GLP-1-based weight loss highlights this distinction and the growing interest in looking beyond total weight loss to muscle quality, function, nutrition, and overall body composition.

In other words, there’s still a lot we don’t know.

And that’s worth saying.

Nutrition May Become More Important When Food Intake Drops

There’s an interesting paradox here.

Someone may need to think more intentionally about nutrition precisely because they’re thinking about food less often.

If appetite is significantly reduced, there simply aren’t as many opportunities during the day to get protein, fiber, healthy fats, fruits, vegetables, and essential vitamins and minerals.

That doesn’t mean everyone using a GLP-1 will develop nutritional deficiencies. But it does help explain why researchers and clinicians are increasingly looking beyond calorie reduction and paying attention to the quality of what people are able to eat.

Current research and clinical guidance are increasingly considering protein adequacy, micronutrient intake, resistance exercise, muscle and bone health, and body composition alongside weight loss itself.

The Bigger Conversation

GLP-1 research is moving quickly.

The early conversation largely centered around how much weight these therapies could help people lose. Now researchers are asking more detailed questions:

• How much of that weight is fat?
• How much is lean tissue?
• How does significant appetite reduction affect nutrition?
• How can muscle and strength be maintained during substantial weight loss?
• Are certain people more vulnerable to losing too much lean mass?
• And what does all of this mean years down the road?

Those questions don’t diminish the significance of GLP-1 research. They make the research more complete.

Because ultimately, understanding weight loss isn’t only about watching the number on the scale go down.

It’s also about understanding what’s happening to the rest of the body along the way.